undefined
EUTM file information

018722811

REYTRIG


June 26, 2022

Trademark Summary

The trademark application REYTRIG was filed by SFJ Pharma X, Inc., a U.S. corporation (the "Applicant"). The application was published for oppositions on July 26, 2022, and it was registered by office on November 2, 2022 without any oppositions.

The application was filed in English (French was selected as the second language).

Appointment and Replacement of representative of the trademark registration was recorded on May 21, 2023. A transfer of the trademark registration was recorded on September 7, 2023. A transfer of the trademark registration was recorded on July 18, 2024. Change of name and professional address of the trademark registration was recorded on August 28, 2024.


Goods And Services

  • The mark was filed in class 5 with Pharmaceutical preparation, namely, a recombinant, human monoclonal antibody antigen-binding fragment designed to reverse the antiplatelet activity of ticagrelor in major bleeding and urgent surgery situations.